(Note: A similarly named but unrelated Vitals RX did receive an FDA warning letter in September 2025, but it is not the same pharmacy.) Additionally, Belle received an FDA warning letter in February of 2026 and was cited for misbranding after putting Belle labels on compounded GLP-1s
If the guarantee is a meaningful factor in your decision, read the Returns page directly and keep your RMA correspondence in writing
Compound 1 was isolated by silica gel column chromatography using a dichloromethane/methanol (DCM:MeOH = 60:1, V/V) eluent (yield: 80%)
ORCID ID: Literature review, drafting, revising and final approval of the version
Lack of effect of the glucagon-like peptide-1 receptor agonist liraglutide on psoriasis in glucose-tolerant patients a randomized placebo-controlled trial
Industry researchers estimate that while about 12% of United States citizens have used a GLP-1 medication for weight loss, 54% of adults who have taken GLP-1s say it was difficult to afford, and 53% say it was still too expensive even if they received insurance coverage for the medication